Assessment of four first-line antituberculosis drug exposure in pulmonary tuberculosis patients with drug-induced hepatotoxicity

Agnija Kivrāne; Viktorija Ulanova; Solveiga Grinberga; Eduards Sevostjanovs; Anda Vīksna; Ilva Pole; Iveta Ozere; Ineta Bogdanova; Maksims Zolovs; Dace Bandere; Renāte Ranka

doi:10.1111/bcpt.13883

Assessment of four first-line antituberculosis drug exposure in pulmonary tuberculosis patients with drug-induced hepatotoxicity

Agnija Kivrāne, Viktorija Ulanova, Solveiga Grinberga, Eduards Sevostjanovs, Anda Vīksna, Ilva Pole, Iveta Ozere, Ineta Bogdanova, Maksims Zolovs, Dace Bandere, Renāte Ranka

Rīga Stradiņš University

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Article number	NORPM-P33
Pages (from-to)	19-20
Journal	Basic and Clinical Pharmacology and Toxicology
Volume	132
Issue number	Suppl.1
DOIs	https://doi.org/10.1111/bcpt.13883
Publication status	Published - Jun 2023
Event	2nd Nordic Conference on Personalized Medicine - Radisson Blu Marina Congress Hotel, Turku, Finland Duration: 14 Jun 2023 → 16 Jun 2023 Conference number: 2 https://norpm2023.fi

Field of Science*

3.2 Clinical medicine
3.1 Basic medicine

Publication Type*

3.3. Publications in conference proceedings indexed in Web of Science and/or Scopus database

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/bcpt.13883

Cite this

Kivrāne, A., Ulanova, V., Grinberga, S., Sevostjanovs, E., Vīksna, A., Pole, I., Ozere, I., Bogdanova, I., Zolovs, M., Bandere, D., & Ranka, R. (2023). Assessment of four first-line antituberculosis drug exposure in pulmonary tuberculosis patients with drug-induced hepatotoxicity. Basic and Clinical Pharmacology and Toxicology, 132(Suppl.1), 19-20. Article NORPM-P33. https://doi.org/10.1111/bcpt.13883

@article{034241be452742509f32ef95dd4c9125,

title = "Assessment of four first-line antituberculosis drug exposure in pulmonary tuberculosis patients with drug-induced hepatotoxicity",

author = "Agnija Kivrāne and Viktorija Ulanova and Solveiga Grinberga and Eduards Sevostjanovs and Anda Vīksna and Ilva Pole and Iveta Ozere and Ineta Bogdanova and Maksims Zolovs and Dace Bandere and Renāte Ranka",

year = "2023",

month = jun,

doi = "10.1111/bcpt.13883",

language = "English",

volume = "132",

pages = "19--20",

journal = "Basic and Clinical Pharmacology and Toxicology",

issn = "1742-7835",

publisher = "Wiley-Blackwell",

number = "Suppl.1",

note = "2nd Nordic Conference on Personalized Medicine ; Conference date: 14-06-2023 Through 16-06-2023",

url = "https://norpm2023.fi",

}

Kivrāne, A , Ulanova, V, Grinberga, S, Sevostjanovs, E, Vīksna, A, Pole, I, Ozere, I, Bogdanova, I, Zolovs, M , Bandere, D & Ranka, R 2023, 'Assessment of four first-line antituberculosis drug exposure in pulmonary tuberculosis patients with drug-induced hepatotoxicity', Basic and Clinical Pharmacology and Toxicology, vol. 132, no. Suppl.1, NORPM-P33, pp. 19-20. https://doi.org/10.1111/bcpt.13883

Assessment of four first-line antituberculosis drug exposure in pulmonary tuberculosis patients with drug-induced hepatotoxicity. / Kivrāne, Agnija ; Ulanova, Viktorija; Grinberga, Solveiga et al.
In: Basic and Clinical Pharmacology and Toxicology, Vol. 132, No. Suppl.1, NORPM-P33, 06.2023, p. 19-20.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - Assessment of four first-line antituberculosis drug exposure in pulmonary tuberculosis patients with drug-induced hepatotoxicity

AU - Kivrāne, Agnija

AU - Ulanova, Viktorija

AU - Grinberga, Solveiga

AU - Sevostjanovs, Eduards

AU - Vīksna, Anda

AU - Pole, Ilva

AU - Ozere, Iveta

AU - Bogdanova, Ineta

AU - Zolovs, Maksims

AU - Bandere, Dace

AU - Ranka, Renāte

N1 - Conference code: 2

PY - 2023/6

Y1 - 2023/6

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=rsu_pure_&SrcAuth=WosAPI&KeyUT=WOS:001307414200034&DestLinkType=FullRecord&DestApp=WOS_CPL

U2 - 10.1111/bcpt.13883

DO - 10.1111/bcpt.13883

M3 - Meeting Abstract

SN - 1742-7835

VL - 132

SP - 19

EP - 20

JO - Basic and Clinical Pharmacology and Toxicology

JF - Basic and Clinical Pharmacology and Toxicology

IS - Suppl.1

M1 - NORPM-P33

T2 - 2nd Nordic Conference on Personalized Medicine

Y2 - 14 June 2023 through 16 June 2023

ER -

Assessment of four first-line antituberculosis drug exposure in pulmonary tuberculosis patients with drug-induced hepatotoxicity

Field of Science*

Publication Type*

UN SDGs

Access to Document

Other files and links

Cite this